rs981093917
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_004519.4(KCNQ3):c.41_49delGCGGCGGCG(p.Gly14_Gly16del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000165 in 1,211,130 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000068 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000018 ( 1 hom. )
Consequence
KCNQ3
NM_004519.4 disruptive_inframe_deletion
NM_004519.4 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.896
Genes affected
KCNQ3 (HGNC:6297): (potassium voltage-gated channel subfamily Q member 3) This gene encodes a protein that functions in the regulation of neuronal excitability. The encoded protein forms an M-channel by associating with the products of the related KCNQ2 or KCNQ5 genes, which both encode integral membrane proteins. M-channel currents are inhibited by M1 muscarinic acetylcholine receptors and are activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of benign familial neonatal convulsions type 2 (BFNC2), also known as epilepsy, benign neonatal type 2 (EBN2). Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 19 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ3 | NM_004519.4 | c.41_49delGCGGCGGCG | p.Gly14_Gly16del | disruptive_inframe_deletion | 1/15 | ENST00000388996.10 | NP_004510.1 | |
KCNQ3 | XM_047421769.1 | c.41_49delGCGGCGGCG | p.Gly14_Gly16del | disruptive_inframe_deletion | 1/15 | XP_047277725.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ3 | ENST00000388996.10 | c.41_49delGCGGCGGCG | p.Gly14_Gly16del | disruptive_inframe_deletion | 1/15 | 1 | NM_004519.4 | ENSP00000373648.3 | ||
KCNQ3 | ENST00000519445.5 | c.41_49delGCGGCGGCG | p.Gly14_Gly16del | disruptive_inframe_deletion | 1/15 | 5 | ENSP00000428790.1 |
Frequencies
GnomAD3 genomes AF: 0.00000676 AC: 1AN: 147890Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
147890
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000179 AC: 19AN: 1063240Hom.: 1 AF XY: 0.0000197 AC XY: 10AN XY: 508208
GnomAD4 exome
AF:
AC:
19
AN:
1063240
Hom.:
AF XY:
AC XY:
10
AN XY:
508208
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000676 AC: 1AN: 147890Hom.: 0 Cov.: 32 AF XY: 0.0000139 AC XY: 1AN XY: 72080
GnomAD4 genome
AF:
AC:
1
AN:
147890
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
72080
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Benign neonatal seizures Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 20, 2022 | This variant has not been reported in the literature in individuals affected with KCNQ3-related conditions. This variant, c.41_49del, results in the deletion of 3 amino acid(s) of the KCNQ3 protein (p.Gly14_Gly16del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at